GO2 for Lung Cancer will celebrate the 20th anniversary of its signature “Simply the Best” Gala on Saturday, November 15, at the Fairmont Hotel in San Francisco This year, the organization will recognize Boehringer Ingelheim with the 2025 GO2 [...]
SAN CARLOS, CA – July 26, 2025 — GO2 for Lung Cancer (GO2) and the Addario Lung Cancer Medical Institute (ALCMI) are proud to announce that Karen Kelly, MD, chief executive officer of the International Association for the Study [...]
New members bring bold leadership and lived experience to accelerate progress for the lung cancer community GO2 for Lung Cancer (GO2) proudly announces the appointment of two new members to its Board of Directors: Margaret Richardson, chief corporate affairs [...]
WASHINGTON, May 1, 2025 – As the nation recognizes May as Women’s Health Month, GO2 for Lung Cancer (GO2) is proud to celebrate a milestone: the Women and Lung Cancer Research and Preventive Services Act of 2025 (H.R. 2319) [...]
WASHINGTON, March 25, 2025 — GO2 for Lung Cancer (GO2) announced it established the Global Advisory Council (GAC), a new group that brings together scientists, medical specialists, and other healthcare professionals from diverse disciplines who focus on GO2’s areas of impact: [...]
Goldwyn highlights the power of early detection to increase lung cancer survivorship WASHINGTON, Jan. 28, 2025 — GO2 for Lung Cancer launched a new awareness campaign to educate the public on the importance of screening for those at risk for [...]
GO2 for Lung Cancer (GO2) recognized lung cancer champions at its 19th Annual Simply the Best Gala in San Francisco on Nov. 2. This event celebrated organizations and individuals across the lung cancer community, including industry partners, survivors, caregivers, [...]
WASHINGTON, Oct. 23, 2024—GO2 for Lung Cancer (GO2) will honor Novocure at its 19th annual “Simply the Best” Gala on Saturday, Nov. 2 at the Fairmont Hotel in San Francisco. Novocure will receive the 2024 “GO2 Excellence Award in [...]
Changes could impact an additional 5 million people at higher risk for lung cancer WASHINGTON, July 9, 2024 – In its ongoing public health partnership, GO2 for Lung Cancer, the American College of Radiology (ACR) and The Society of Thoracic [...]
Clinical Trial Aims to Unlock the Origins of Lung Cancer WASHINGTON and BOSTON, April 17, 2024 – In a promising step forward, GO2 for Lung Cancer (GO2), Dana-Farber Cancer Institute (Dana-Farber), and the Addario Lung Cancer Medical Institute (ALCMI), [...]